APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tigecycline

Tigecycline is the first drug in the glycyltetracycline class (a modified form of minocycline). It is a new broad-spectrum intravenous antibiotic developed by pfizer (wyeth). It is effective against drug-resistant mrsa.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Tigecycline is the first drug in the glycyltetracycline class (a modified form of minocycline). It is a new broad-spectrum intravenous antibiotic developed by pfizer (wyeth). It is effective against drug-resistant mrsa.

Selected research

Industry Growth & Trends

Global Tigecycline Industry Growth and Trends Forecast to 2032

28 December 2025108 pages

Choose your research edition.

Industry ResearchTigecycline Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Tigecycline Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Tigecycline Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tigecycline Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Tigecycline Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Tigecycline is the first drug in the glycyltetracycline class (a modified form of minocycline). It is a new broad-spectrum intravenous antibiotic developed by pfizer (wyeth). It is effective against drug-resistant mrsa.

Global Tigecycline Sales Channel is wide, like Hospital Pharmacies , Retail Pharmacies. Hospital Pharmacies is the largest consumer channel.

Tigecycline can be mainly divided into Generic Drug, Original Drug.

Read the full market overview

In 2019, North America dominated the global Tigecycline market, accounting for more than 34% of the total revenue.

Report Scope

This report provides a structured, data-driven view of the global Tigecycline market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tigecycline market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tigecycline market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tigecycline.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tigecycline market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tigecycline Market by Company

Pfizer (Wyeth)

Sino Biopharmaceutical

Zhejiang Hisun Pharma

Jiangsu Hansoh Pharmaceutical

Abbott

Natco Pharma

Lyka Labs Limited

Fresenius Kabi

Sandoz

APOTEX

Accord Healthcare

Amneal Pharmaceuticals

Tigecycline Segment by Type

Original Drug

Generic Drug

Tigecycline Segment by Application

Hospital Pharmacies

Retail Pharmacies

Tigecycline Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tigecycline market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tigecycline and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tigecycline.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tigecycline manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tigecycline in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Original Drug Table 2. Major Company of Generic Drug Table 3. Global Tigecycline Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Tigecycline Sales by Type (2021-2026) & (K Units) Table 5. Global Tigecycline Sales Market Share in Volume by Type (2021-2026) Table 6. Global Tigecycline Sales by Type (2021-2026) & (US$ Million) Table 7. Global Tigecycline Sales Market Share in Value by Type (2021-2026) Table 8. Global Tigecycline Price by Type (2021-2026) & (USD/Unit) Table 9. Global Tigecycline Sales by Type (2027-2032) & (K Units) Table 10. Global Tigecycline Sales Market Share in Volume by Type (2027-2032) Table 11. Global Tigecycline Sales by Type (2027-2032) & (US$ Million) Table 12. Global Tigecycline Sales Market Share in Value by Type (2027-2032) Table 13. Global Tigecycline Price by Type (2027-2032) & (USD/Unit) Table 14. North America Tigecycline Sales by Type (2021-2026) & (K Units) Table 15. North America Tigecycline Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Tigecycline Sales by Type (2021-2026) & (K Units) Table 17. Europe Tigecycline Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Tigecycline Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Tigecycline Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Tigecycline Sales by Type (2021-2026) & (K Units) Table 21. Latin America Tigecycline Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Tigecycline Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Tigecycline Sales by Type (2021-2026) & (US$ Million) Table 24. Tigecycline Industry Trends Table 25. Tigecycline Industry Drivers Table 26. Tigecycline Industry Opportunities and Challenges Table 27. Tigecycline Industry Restraints Table 28. Global Tigecycline Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Tigecycline Revenue Market Share by Company (2021-2026) Table 30. Global Tigecycline Sales by Company (2021-2026) & (K Units) Table 31. Global Tigecycline Sales Share by Company (2021-2026) Table 32. Global Tigecycline Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Tigecycline Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Tigecycline Major Company Production Sites and Headquarters Table 35. Global Tigecycline Company, Product Type & Application Table 36. Global Tigecycline Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Tigecycline by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Tigecycline Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Tigecycline Sales by Region (2021-2026) & (K Units) Table 41. Global Tigecycline Sales Market Share in Volume by Region (2021-2026) Table 42. Global Tigecycline Sales by Region (2021-2026) & (US$ Million) Table 43. Global Tigecycline Sales Market Share in Value by Region (2021-2026) Table 44. Global Tigecycline Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Tigecycline Sales by Region (2027-2032) & (K Units) Table 46. Global Tigecycline Sales Market Share in Volume by Region (2027-2032) Table 47. Global Tigecycline Sales by Region (2027-2032) & (US$ Million) Table 48. Global Tigecycline Sales Market Share in Value by Region (2027-2032) Table 49. Global Tigecycline Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Tigecycline Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Tigecycline Sales by Application (2021-2026) & (K Units) Table 52. Global Tigecycline Sales Market Share in Volume by Application (2021-2026) Table 53. Global Tigecycline Sales by Application (2021-2026) & (US$ Million) Table 54. Global Tigecycline Sales Market Share in Value by Application (2021-2026) Table 55. Global Tigecycline Price by Application (2021-2026) & (USD/Unit) Table 56. Global Tigecycline Sales by Application (2027-2032) & (K Units) Table 57. Global Tigecycline Sales Market Share in Volume by Application (2027-2032) Table 58. Global Tigecycline Sales by Application (2027-2032) & (US$ Million) Table 59. Global Tigecycline Sales Market Share in Value by Application (2027-2032) Table 60. Global Tigecycline Price by Application (2027-2032) & (USD/Unit) Table 61. North America Tigecycline Sales by Application (2021-2026) & (K Units) Table 62. North America Tigecycline Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Tigecycline Sales by Application (2021-2026) & (K Units) Table 64. Europe Tigecycline Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Tigecycline Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Tigecycline Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Tigecycline Sales by Application (2021-2026) & (K Units) Table 68. Latin America Tigecycline Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Tigecycline Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Tigecycline Sales by Application (2021-2026) & (US$ Million) Table 71. Pfizer (Wyeth) Company Information Table 72. Pfizer (Wyeth) Business Overview Table 73. Pfizer (Wyeth) Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Pfizer (Wyeth) Tigecycline Product Portfolio Table 75. Pfizer (Wyeth) Recent Development Table 76. Sino Biopharmaceutical Company Information Table 77. Sino Biopharmaceutical Business Overview Table 78. Sino Biopharmaceutical Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Sino Biopharmaceutical Tigecycline Product Portfolio Table 80. Sino Biopharmaceutical Recent Development Table 81. Zhejiang Hisun Pharma Company Information Table 82. Zhejiang Hisun Pharma Business Overview Table 83. Zhejiang Hisun Pharma Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Zhejiang Hisun Pharma Tigecycline Product Portfolio Table 85. Zhejiang Hisun Pharma Recent Development Table 86. Jiangsu Hansoh Pharmaceutical Company Information Table 87. Jiangsu Hansoh Pharmaceutical Business Overview Table 88. Jiangsu Hansoh Pharmaceutical Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Jiangsu Hansoh Pharmaceutical Tigecycline Product Portfolio Table 90. Jiangsu Hansoh Pharmaceutical Recent Development Table 91. Abbott Company Information Table 92. Abbott Business Overview Table 93. Abbott Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Abbott Tigecycline Product Portfolio Table 95. Abbott Recent Development Table 96. Natco Pharma Company Information Table 97. Natco Pharma Business Overview Table 98. Natco Pharma Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Natco Pharma Tigecycline Product Portfolio Table 100. Natco Pharma Recent Development Table 101. Lyka Labs Limited Company Information Table 102. Lyka Labs Limited Business Overview Table 103. Lyka Labs Limited Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Lyka Labs Limited Tigecycline Product Portfolio Table 105. Lyka Labs Limited Recent Development Table 106. Fresenius Kabi Company Information Table 107. Fresenius Kabi Business Overview Table 108. Fresenius Kabi Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Fresenius Kabi Tigecycline Product Portfolio Table 110. Fresenius Kabi Recent Development Table 111. Sandoz Company Information Table 112. Sandoz Business Overview Table 113. Sandoz Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Sandoz Tigecycline Product Portfolio Table 115. Sandoz Recent Development Table 116. APOTEX Company Information Table 117. APOTEX Business Overview Table 118. APOTEX Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. APOTEX Tigecycline Product Portfolio Table 120. APOTEX Recent Development Table 121. Accord Healthcare Company Information Table 122. Accord Healthcare Business Overview Table 123. Accord Healthcare Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. Accord Healthcare Tigecycline Product Portfolio Table 125. Accord Healthcare Recent Development Table 126. Amneal Pharmaceuticals Company Information Table 127. Amneal Pharmaceuticals Business Overview Table 128. Amneal Pharmaceuticals Tigecycline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 129. Amneal Pharmaceuticals Tigecycline Product Portfolio Table 130. Amneal Pharmaceuticals Recent Development Table 131. North America Tigecycline Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. North America Tigecycline Sales by Country (2021-2026) & (K Units) Table 133. North America Tigecycline Sales Market Share by Country (2021-2026) Table 134. North America Tigecycline Sales Forecast by Country (2027-2032) & (K Units) Table 135. North America Tigecycline Sales Market Share Forecast by Country (2027-2032) Table 136. North America Tigecycline Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Tigecycline Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Tigecycline Market Share by Country (2021-2026) Table 139. North America Tigecycline Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Tigecycline Market Share Forecast by Country (2027-2032) Table 141. Europe Tigecycline Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Europe Tigecycline Sales by Country (2021-2026) & (K Units) Table 143. Europe Tigecycline Sales Market Share by Country (2021-2026) Table 144. Europe Tigecycline Sales Forecast by Country (2027-2032) & (K Units) Table 145. Europe Tigecycline Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Tigecycline Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Tigecycline Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Tigecycline Market Share by Country (2021-2026) Table 149. Europe Tigecycline Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Tigecycline Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Tigecycline Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Tigecycline Sales by Country (2021-2026) & (K Units) Table 153. Asia-Pacific Tigecycline Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Tigecycline Sales Forecast by Country (2027-2032) & (K Units) Table 155. Asia-Pacific Tigecycline Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Tigecycline Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Tigecycline Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Tigecycline Market Share by Country (2021-2026) Table 159. Asia-Pacific Tigecycline Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Tigecycline Market Share Forecast by Country (2027-2032) Table 161. Latin America Tigecycline Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Latin America Tigecycline Sales by Country (2021-2026) & (K Units) Table 163. Latin America Tigecycline Sales Market Share by Country (2021-2026) Table 164. Latin America Tigecycline Sales Forecast by Country (2027-2032) & (K Units) Table 165. Latin America Tigecycline Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Tigecycline Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Tigecycline Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Tigecycline Market Share by Country (2021-2026) Table 169. Latin America Tigecycline Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Tigecycline Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Tigecycline Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Tigecycline Sales by Country (2021-2026) & (K Units) Table 173. Middle East and Africa Tigecycline Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Tigecycline Sales Forecast by Country (2027-2032) & (K Units) Table 175. Middle East and Africa Tigecycline Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Tigecycline Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Tigecycline Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Tigecycline Market Share by Country (2021-2026) Table 179. Middle East and Africa Tigecycline Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Tigecycline Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Tigecycline Distributors List Table 184. Tigecycline Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Tigecycline Image Figure 2. Global Tigecycline Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tigecycline Market Size (2021-2032) & (US$ Million) Figure 4. Global Tigecycline Sales (2021-2032) & (K Units) Figure 5. Original Drug Image Figure 6. Global Original Drug Sales YoY Growth (2021-2032) & (K Units) Figure 7. Generic Drug Image Figure 8. Global Generic Drug Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Tigecycline Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Tigecycline Market Share by Type 2025 VS 2032 Figure 11. North America Tigecycline Sales Market Share in Volume by Type in 2025 Figure 12. North America Tigecycline Sales Market Share in Value by Type in 2025 Figure 13. Europe Tigecycline Sales Market Share in Volume by Type in 2025 Figure 14. Europe Tigecycline Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Tigecycline Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Tigecycline Sales Market Share in Value by Type in 2025 Figure 17. Latin America Tigecycline Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Tigecycline Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Tigecycline Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Tigecycline Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Tigecycline Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Pharmacies Image Figure 24. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 25. Retail Pharmacies Image Figure 26. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Tigecycline Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Tigecycline Market Share by Application 2025 VS 2032 Figure 29. North America Tigecycline Sales Market Share in Volume by Application in 2025 Figure 30. North America Tigecycline Sales Market Share in Value by Application in 2025 Figure 31. Europe Tigecycline Sales Market Share in Volume by Application in 2025 Figure 32. Europe Tigecycline Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Tigecycline Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Tigecycline Sales Market Share in Value by Application in 2025 Figure 35. Latin America Tigecycline Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Tigecycline Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Tigecycline Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Tigecycline Sales Market Share in Value by Application in 2025 Figure 39. North America Tigecycline Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Tigecycline Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Tigecycline Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Tigecycline Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Tigecycline Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Tigecycline Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Tigecycline Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Tigecycline Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Tigecycline Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Tigecycline Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Tigecycline Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Tigecycline Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Tigecycline Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Tigecycline Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Tigecycline Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Tigecycline Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Tigecycline Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Tigecycline Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Tigecycline Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Tigecycline Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Tigecycline Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Tigecycline Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospital Pharmacies
  • Retail Pharmacies
Companies covered
  • Pfizer (Wyeth)
  • Sino Biopharmaceutical
  • Zhejiang Hisun Pharma
  • Jiangsu Hansoh Pharmaceutical
  • Abbott
  • Natco Pharma
  • Lyka Labs Limited
  • Fresenius Kabi
  • Sandoz
  • APOTEX
  • Accord Healthcare
  • Amneal Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tigecycline Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tigecycline Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tigecycline Market by Type
  6. 1.3.1 Original Drug
  7. 1.3.2 Generic Drug
  8. 1.4 Global Tigecycline Market Size by Type
  9. 1.4.1 Global Tigecycline Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Tigecycline Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Tigecycline Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Tigecycline Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Tigecycline Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Tigecycline Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Tigecycline Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Tigecycline Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tigecycline Industry Trends
  2. 2.2 Tigecycline Industry Drivers
  3. 2.3 Tigecycline Industry Opportunities and Challenges
  4. 2.4 Tigecycline Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tigecycline Revenue (2021-2026)
  2. 3.2 Global Top Players by Tigecycline Sales (2021-2026)
  3. 3.3 Global Top Players by Tigecycline Price (2021-2026)
  4. 3.4 Global Tigecycline Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tigecycline Major Company Production Sites & Headquarters
  6. 3.6 Global Tigecycline Company, Product Type & Application
  7. 3.7 Global Tigecycline Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tigecycline Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tigecycline Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tigecycline Tier 1, Tier 2, and Tier 3
4 Tigecycline Regional Status and Outlook
  1. 4.1 Global Tigecycline Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tigecycline Historic Market Size by Region
  3. 4.2.1 Global Tigecycline Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tigecycline Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tigecycline Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tigecycline Forecasted Market Size by Region
  7. 4.3.1 Global Tigecycline Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tigecycline Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tigecycline Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tigecycline by Application
  1. 5.1 Tigecycline Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Retail Pharmacies
  4. 5.2 Global Tigecycline Market Size by Application
  5. 5.2.1 Global Tigecycline Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Tigecycline Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Tigecycline Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Tigecycline Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Tigecycline Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Tigecycline Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Tigecycline Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Tigecycline Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer (Wyeth)
  2. 6.1.1 Pfizer (Wyeth) Company Information
  3. 6.1.2 Pfizer (Wyeth) Business Overview
  4. 6.1.3 Pfizer (Wyeth) Tigecycline Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer (Wyeth) Tigecycline Product Portfolio
  6. 6.1.5 Pfizer (Wyeth) Recent Developments
  7. 6.2 Sino Biopharmaceutical
  8. 6.2.1 Sino Biopharmaceutical Company Information
  9. 6.2.2 Sino Biopharmaceutical Business Overview
  10. 6.2.3 Sino Biopharmaceutical Tigecycline Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sino Biopharmaceutical Tigecycline Product Portfolio
  12. 6.2.5 Sino Biopharmaceutical Recent Developments
  13. 6.3 Zhejiang Hisun Pharma
  14. 6.3.1 Zhejiang Hisun Pharma Company Information
  15. 6.3.2 Zhejiang Hisun Pharma Business Overview
  16. 6.3.3 Zhejiang Hisun Pharma Tigecycline Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Zhejiang Hisun Pharma Tigecycline Product Portfolio
  18. 6.3.5 Zhejiang Hisun Pharma Recent Developments
  19. 6.4 Jiangsu Hansoh Pharmaceutical
  20. 6.4.1 Jiangsu Hansoh Pharmaceutical Company Information
  21. 6.4.2 Jiangsu Hansoh Pharmaceutical Business Overview
  22. 6.4.3 Jiangsu Hansoh Pharmaceutical Tigecycline Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Jiangsu Hansoh Pharmaceutical Tigecycline Product Portfolio
  24. 6.4.5 Jiangsu Hansoh Pharmaceutical Recent Developments
  25. 6.5 Abbott
  26. 6.5.1 Abbott Company Information
  27. 6.5.2 Abbott Business Overview
  28. 6.5.3 Abbott Tigecycline Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Abbott Tigecycline Product Portfolio
  30. 6.5.5 Abbott Recent Developments
  31. 6.6 Natco Pharma
  32. 6.6.1 Natco Pharma Company Information
  33. 6.6.2 Natco Pharma Business Overview
  34. 6.6.3 Natco Pharma Tigecycline Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Natco Pharma Tigecycline Product Portfolio
  36. 6.6.5 Natco Pharma Recent Developments
  37. 6.7 Lyka Labs Limited
  38. 6.7.1 Lyka Labs Limited Company Information
  39. 6.7.2 Lyka Labs Limited Business Overview
  40. 6.7.3 Lyka Labs Limited Tigecycline Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lyka Labs Limited Tigecycline Product Portfolio
  42. 6.7.5 Lyka Labs Limited Recent Developments
  43. 6.8 Fresenius Kabi
  44. 6.8.1 Fresenius Kabi Company Information
  45. 6.8.2 Fresenius Kabi Business Overview
  46. 6.8.3 Fresenius Kabi Tigecycline Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Fresenius Kabi Tigecycline Product Portfolio
  48. 6.8.5 Fresenius Kabi Recent Developments
  49. 6.9 Sandoz
  50. 6.9.1 Sandoz Company Information
  51. 6.9.2 Sandoz Business Overview
  52. 6.9.3 Sandoz Tigecycline Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sandoz Tigecycline Product Portfolio
  54. 6.9.5 Sandoz Recent Developments
  55. 6.10 APOTEX
  56. 6.10.1 APOTEX Company Information
  57. 6.10.2 APOTEX Business Overview
  58. 6.10.3 APOTEX Tigecycline Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 APOTEX Tigecycline Product Portfolio
  60. 6.10.5 APOTEX Recent Developments
  61. 6.11 Accord Healthcare
  62. 6.11.1 Accord Healthcare Company Information
  63. 6.11.2 Accord Healthcare Business Overview
  64. 6.11.3 Accord Healthcare Tigecycline Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Accord Healthcare Tigecycline Product Portfolio
  66. 6.11.5 Accord Healthcare Recent Developments
  67. 6.12 Amneal Pharmaceuticals
  68. 6.12.1 Amneal Pharmaceuticals Company Information
  69. 6.12.2 Amneal Pharmaceuticals Business Overview
  70. 6.12.3 Amneal Pharmaceuticals Tigecycline Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Amneal Pharmaceuticals Tigecycline Product Portfolio
  72. 6.12.5 Amneal Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Tigecycline Sales by Country
  2. 7.1.1 North America Tigecycline Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tigecycline Sales by Country (2021-2026)
  4. 7.1.3 North America Tigecycline Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tigecycline Market Size by Country
  6. 7.2.1 North America Tigecycline Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tigecycline Market Size by Country (2021-2026)
  8. 7.2.3 North America Tigecycline Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tigecycline Sales by Country
  2. 8.1.1 Europe Tigecycline Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tigecycline Sales by Country (2021-2026)
  4. 8.1.3 Europe Tigecycline Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tigecycline Market Size by Country
  6. 8.2.1 Europe Tigecycline Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tigecycline Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tigecycline Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tigecycline Sales by Country
  2. 9.1.1 Asia-Pacific Tigecycline Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tigecycline Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tigecycline Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tigecycline Market Size by Country
  6. 9.2.1 Asia-Pacific Tigecycline Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tigecycline Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tigecycline Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tigecycline Sales by Country
  2. 10.1.1 South America Tigecycline Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tigecycline Sales by Country (2021-2026)
  4. 10.1.3 South America Tigecycline Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tigecycline Market Size by Country
  6. 10.2.1 South America Tigecycline Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tigecycline Market Size by Country (2021-2026)
  8. 10.2.3 South America Tigecycline Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tigecycline Sales by Country
  2. 11.1.1 Middle East and Africa Tigecycline Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tigecycline Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tigecycline Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tigecycline Market Size by Country
  6. 11.2.1 Middle East and Africa Tigecycline Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tigecycline Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tigecycline Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tigecycline Value Chain Analysis
  2. 12.1.1 Tigecycline Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tigecycline Production Mode & Process
  7. 12.2 Tigecycline Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tigecycline Distributors
  10. 12.2.3 Tigecycline Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst